# Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada

> **NCT04080856** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 100 (actual)

## Conditions studied

- Endometriosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04080856
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-04
- **Primary completion:** 2021-09-27
- **Final completion:** 2021-09-27
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04080856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04080856, "Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04080856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*